Author: Dale HewettTL;DR – Hemp-derived CBD with 0.3% THC or less is fully legal in Washington, D.C. under the federal 2018 Farm Bill. Because D.C. is a federal district rather than a state, federal hemp law applies directly, and D.C. has not enacted conflicting local restrictions on hemp-derived CBD. No license, medical card, or possession limit applies to consumers. D.C. also has a medical marijuana program under D.C. Code § 7-1671.01 et seq. and allows personal marijuana possession and home cultivation under Initiative 71 (2015). Hemp-derived CBD operates under its own framework separately from both. Always verify third-party certificates of analysis before purchasing.
Washington D.C.’s Legal Framework for Hemp-Derived CBD
Hemp-derived CBD is fully legal in Washington, D.C. The federal Agriculture Improvement Act of 2018—the 2018 Farm Bill—removed hemp from the Controlled Substances Act and defined hemp as cannabis with 0.3% THC or less by dry weight. Because D.C. is a federal district subject to congressional oversight rather than a traditional state, federal law applies with particular directness. The 2018 Farm Bill’s hemp provisions create a clear legal basis for hemp-derived CBD products in D.C. without requiring additional local legislation.
D.C. has not enacted local restrictions on hemp-derived CBD beyond what federal law requires. Consumers in D.C. need no license, no registration, and no medical card to purchase, possess, or use hemp-derived CBD. There are no local possession limits on hemp-derived CBD products—you may legally hold any quantity of compliant products. The 0.3% THC threshold is the operative standard, and products meeting that standard are legal throughout the District.
D.C. does not have a traditional state department of agriculture hemp licensing program the way states do. However, hemp businesses operating in D.C.—growers (if any), processors, and retailers—must comply with applicable federal regulations. This federal-first regulatory posture makes D.C.’s hemp CBD framework relatively straightforward for consumers even as the local cannabis regulatory picture is more complex.
D.C.’s Cannabis Landscape: Initiative 71 and the Medical Program
Washington, D.C. has a notably complex cannabis policy history shaped by its unique federal district status. In 2010, D.C. enacted its Medical Marijuana Program under D.C. Code § 7-1671.01 et seq., administered by the D.C. Department of Health and later moved under the Alcohol Beverage and Cannabis Administration (ABCA). The medical program allows qualifying patients to access cannabis products from licensed dispensaries with a physician recommendation and registration with the District.
In 2015, D.C. voters approved Initiative 71 by a wide margin, legalizing personal possession of up to two ounces of marijuana for adults 21 and older and allowing home cultivation of up to six plants. However, Initiative 71 did not authorize commercial retail cannabis sales—and for years, congressional budget riders blocked D.C. from spending funds to establish a regulated retail market. This created D.C.’s well-known “gifting” economy, where cannabis was transferred between adults as a “gift” alongside a nominal paid transaction. D.C. has been working to establish a formal regulated adult-use retail market, and the legal and regulatory landscape for commercial cannabis sales in the District has continued to evolve.
Hemp-derived CBD is entirely separate from Initiative 71, the medical marijuana program, and whatever recreational retail framework D.C. may have established or be developing. Hemp CBD is a federally legal agricultural product available at general retail throughout the District without any of the complexity that surrounds D.C.’s marijuana regulatory environment.
Delta-8 THC and Novel Hemp Cannabinoids in D.C.
Delta-8 THC is a mildly psychoactive cannabinoid synthesized from hemp CBD through chemical isomerization. D.C. has not enacted local legislation specifically banning delta-8 from hemp, and products containing it are sold throughout the District. However, as a federal district, D.C. is particularly sensitive to federal regulatory positions, and the DEA has suggested that synthetically derived THC isomers may not fall within the 2018 Farm Bill’s hemp protections. The ABCA’s expanding oversight of cannabis-related products in D.C. may also eventually address novel hemp cannabinoids explicitly.
For consumers who want the clearest legal standing and the most established safety profile, standard hemp-derived CBD, CBG, or CBN products remain the most straightforward option in D.C. The regulatory picture for delta-8 and similar compounds continues to evolve at both the federal and local levels.
Why Third-Party Testing Matters for D.C. CBD Consumers
D.C.’s hemp-derived CBD market is legally clear, but product quality varies across the market. FDA analyses and independent testing have found that a meaningful proportion of commercially available CBD products are inaccurately labeled—overstating CBD potency, understating THC content, or both. Some products have tested above the 0.3% THC threshold, which would classify them as marijuana under federal law.
Unlike marijuana-derived products sold at D.C.’s licensed dispensaries—which face mandatory ABCA testing and labeling requirements—hemp-derived CBD at general retail is not subject to the same mandatory testing regime. Consumer verification through Certificates of Analysis (COAs) is therefore the essential quality safeguard. Reputable hemp CBD brands use independent, ISO/IEC 17025-accredited laboratories to measure actual cannabinoid content and screen for contaminants including pesticide residues, heavy metals (lead, arsenic, mercury, cadmium), residual solvents, and microbial pathogens.
Look for a QR code on the product label linking to the current batch’s COA. Confirm that delta-9 THC is at or below 0.3%, that CBD potency matches the label claim, and that all contaminant screens show passing results. Products without accessible, current COA documentation are best avoided regardless of where they are sold in the District.
Where to Buy CBD in Washington, D.C.
Hemp-derived CBD products are widely available throughout D.C. at dedicated CBD and wellness retailers, health food and supplement stores, pharmacies, and some general retail and convenience outlets. D.C.’s dense urban environment and health-conscious population have produced a robust CBD retail market. Online purchasing from nationally established hemp brands is also fully legal for D.C. residents and typically provides the most comprehensive access to third-party testing documentation.
D.C. does not maintain a separate registry of approved hemp CBD retailers beyond its licensed cannabis dispensary network. Consumer diligence is the primary quality mechanism. Look for brands with consistent third-party testing histories, transparent COA access, and clear sourcing information. Licensed ABCA dispensaries may also carry hemp-derived CBD products alongside marijuana-derived offerings, and those products benefit from the dispensary’s mandatory testing oversight.
Traveling With CBD in Washington, D.C.
Traveling within D.C. with hemp-derived CBD is entirely lawful. D.C. is bordered by Maryland and Virginia, both of which have their own cannabis frameworks. Maryland has legalized recreational marijuana; Virginia has also legalized recreational marijuana. Hemp-derived CBD is legal in both states, so crossing the D.C. border with hemp CBD is generally without legal issue. For travel to other states or internationally, verify the destination’s current rules.
Air travelers departing from Reagan National Airport, Dulles International Airport, or BWI with hemp-derived CBD are generally permitted to carry compliant products under TSA guidelines. TSA focuses on security screening rather than cannabis detection, but carrying your product’s COA is a practical precaution that can resolve questions at any checkpoint.
Does D.C.’s Initiative 71 affect hemp-derived CBD?
No. Initiative 71 governs personal marijuana possession and home cultivation in D.C.—it applies to cannabis with THC above 0.3%. Hemp-derived CBD is a separate category under federal law and does not interact with Initiative 71 in any way. You do not need to invoke Initiative 71 or any cannabis law to purchase or possess hemp-derived CBD in D.C.
Do I need a medical marijuana card to buy hemp CBD in D.C.?
No. D.C.’s medical marijuana program under D.C. Code § 7-1671.01 et seq. governs marijuana-derived products with THC above 0.3%. Hemp-derived CBD is available to any D.C. consumer at general retail without a card, physician recommendation, or registration of any kind. The two systems are legally separate.
Is there a possession limit for hemp CBD in D.C.?
No. D.C. does not impose possession limits on hemp-derived CBD products. You may legally hold any quantity of compliant hemp-derived CBD. This is distinct from marijuana under Initiative 71, which caps personal possession at two ounces of flower for adults 21 and older.
Will hemp CBD show up on a drug test?
Standard drug tests screen for THC metabolites, not CBD. Hemp-derived CBD products at 0.3% THC or less carry low risk of triggering a positive result under typical testing thresholds. However, highly sensitive tests, heavy use, or product mislabeling could introduce some risk. Review your product’s COA for exact THC content and consult your testing administrator about sensitivity thresholds if you have concerns.
Can hemp CBD be added to food and beverages sold commercially in D.C.?
Because D.C. is a federal district, the FDA’s position on CBD in commercial food and beverage products applies directly: CBD has not been approved as a food additive or dietary supplement ingredient, and adding it to commercial food products is not currently authorized. Personal home preparation of food containing hemp-derived CBD carries no legal restriction, but commercial food establishments in D.C. selling CBD-infused products operate in a regulatory gray zone pending FDA action.
Related State CBD Law Guides
CBD regulations vary from state to state. If you are researching hemp-derived CBD laws in a neighboring or comparable state, the following guides cover similar ground. For a complete federal overview, see our guide to federal hemp law in the United States.
Explore: CBD Laws in Rhode Island | CBD Laws in Connecticut | CBD Laws in Pennsylvania
References
Agriculture Improvement Act of 2018, Pub. L. No. 115-334, 132 Stat. 4490 (2018). https://www.congress.gov/bill/115th-congress/house-bill/2
District of Columbia Medical Marijuana Program, D.C. Code § 7-1671.01 et seq. https://code.dccouncil.gov/us/dc/council/code/titles/7/chapters/16B
Initiative 71, Legalization of Possession of Minimal Amounts of Marijuana for Personal Use (2015). https://dcregs.dc.gov/Common/DCMR/SectionList.aspx?SectionId=5940948
D.C. Alcohol Beverage and Cannabis Administration. (2024). Cannabis. https://abca.dc.gov/service/cannabis
U.S. Food and Drug Administration. (2020). FDA advances work related to cannabidiol products with focus on protecting public health, providing market clarity. https://www.fda.gov/news-events/press-announcements/fda-advances-work-related-cannabidiol-products-focus-protecting-public-health-providing-market
U.S. Drug Enforcement Administration. (2020). Implementation of the Agriculture Improvement Act of 2018. 85 Fed. Reg. 51,639. https://www.federalregister.gov/documents/2020/08/21/2020-17356/implementation-of-the-agriculture-improvement-act-of-2018
